*OFFICIAL* IX BIOPHARM (SGX: 42C)

winorlose

Arch-Supremacy Member
Joined
Jul 23, 2012
Messages
16,647
Reaction score
357
http://infopub.sgx.com/Apps?A=COW_C...esults from Pharmacokinetic Study of BnoX.pdf


IX BIOPHARMA REPORTS POSITIVE RESULTS FROM PHARMACOKINETIC STUDY OF BNOX
Singapore, 15 May 2017 – Homegrown specialty pharmaceutical company iX Biopharma Ltd. (“iX Biopharma” or, together with its subsidiaries, “the Group”) is pleased to announce the results of BUP001, a pharmacokinetic study of its novel sublingual buprenorphine wafer, BnoX. BnoX, which uses the Group’s patented sublingual drug delivery technology, WaferiX, is one of the Group’s products under development for pain management.

The primary objective of the study was to investigate the absolute bioavailability and tolerability of BnoX. (It is generally known that the oral bioavailability of buprenorphine is very low and variable, leading to unpredictable clinical effects).

The absolute bioavailability of BnoX was 45.4% with time to maximum plasma concentration (Tmax) of 1 hour. This compares favourably to the only marketed sublingual formulation for pain, Temgesic® which has a reported bioavailability of 35% and Tmax of 2-4 hours1. BnoX wafers were safe and well-tolerated.
Dr Janakan Krishnarajah, Chief Medical Officer said: “We are very pleased with the outcomes from BUP001 study. The results suggest that BnoX appears to have a superior pharmacokinetic profile compared to the marketed Temgesic® sublingual tablet, and may provide enhanced clinical utility in the management of both acute and chronic pain.”

Dr Krishnarajah will be presenting this exciting study result at the Annual Scientific Meeting of the Australian and New Zealand College of Anaesthetists to be held in Brisbane, Australia on Monday, 15 May 2017. This is the premier annual conference for anaesthetists in Australia and New Zealand, and 1,800 attendees are expected.
 

Mecisteus

Great Supremacy Member
Joined
Jun 16, 2002
Messages
52,658
Reaction score
10,628
Yeah this reminds me of Biosensors.

Stocks in this sector can deliver superior returns and disappoint spectacularly on any failure. So timing is very crucial.

I am invested in a small cap biotech index stocks for US market. This one is much more diversified and safer.
 
Last edited:

Tool18

Arch-Supremacy Member
Joined
Aug 15, 2000
Messages
17,528
Reaction score
0
Yes small pie 15000 shares at 0.285,

Missed the lower boat

Vested for their potential into China market and their owner of patents

Loss making past few years but I see the revenue start coming in with the turnaround from China
 
Important Forum Advisory Note
This forum is moderated by volunteer moderators who will react only to members' feedback on posts. Moderators are not employees or representatives of HWZ. Forum members and moderators are responsible for their own posts.

Please refer to our Community Guidelines and Standards, Terms of Service and Member T&Cs for more information.
Top